Google
CRBP 株価分析 — Corbus Pharmaceuticals Holding (Healthcare >> Biotechnology)
CRBP に関するよくある質問
CRBPのROE（自己資本利益率）は？
Corbus Pharmaceuticals HoldingのROEは-66.90%です。
CRBPの配当利回りは？
Corbus Pharmaceuticals Holdingの配当利回りは0.00%です。
CRBPの品質スコア（Quality Score）は？
当社のAIはCRBPの総合財務品質を100点中23点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
CRBPは今が買い時ですか？
当社AIのタイミングスコアは100点中96点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
CRBPはどのセクターに属しますか？
Corbus Pharmaceuticals HoldingはHealthcare >> Biotechnologyセクターに分類されます（NASDAQ市場）
CRBP AI Analysis Summary
Our AI summary for CRBP: Corbus Pharmaceuticals Holding (NASDAQ), Healthcare >> Biotechnology sector. The stock currently trades at a P/E of 0.00, ROE of -66.90%, a dividend yield of 0.00%. Its financial Quality Score stands at 23/100 — fundamentals below the market average. The AI Timing Score is 96/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 9.57
Price
0.17
(1.81%)
Day Change
|
|
|---|
CRBP, ファンダメンタルスコアはnot good ( ファンダメンタル = 23) but テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
ROEの伸びが低い
昨年度のROEが一昨年比で低い
ROEが昨年度比で低い
ROAがROEに比べて低い
Last-year ROA is lower than last-2-years ROA.
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Deepscope 分析 |
|
47% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 76 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 9.57 |
| PBV / Sector |
1.38 / 44,105.10
GOOD
|
| Earning Per Share | -4.64 |
| PE / Sector |
N/A / 19.37
|
| PEG or PE/Growth / Sector |
N/A / 1.06
|
| Average 1M Daily Value |
2.27 M
GREAT
|
| Average 1W Daily Value |
2.06 M
GREAT
|
| Timing Factors |
|
71% |
| Financial Health |
|
41% |
| ポイントになる統計 |
|
37% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-08-06 07:59:49 |
| Symbol | CRBP |
| Name | CORBUS PHARMACEUTICALS HOLDING |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 18.53 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 174.16 / 9,702.21 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 500 River Ridge Drive, Norwood, MA, United States, 02062
Phone: 617 963 0100
Website: https://www.corbuspharma.com
Sector: Healthcare >> Biotechnology
Description: Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatment of obesity. The company was incorporated in 2009 and is headquartered in Norwood, Massachusetts.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
